Atlas market file · Equity · United States
Meta Platforms Inc.META
- Last close
- 578.85
- Change
- -3.38%
- 96-bar range
- 520.26 – 691.52
- As of
- 12 Aug 2026
Meta Platforms Inc. is a listed company listed as META on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- NASDAQ symbol identity
- Chart rail
- TradingView
- File state
- Public profile
United States · NASDAQ · Equity
Turn META into a decision-ready research file.
Start with the resolved United States market identity, then move through the latest available chart, cited evidence and open research questions without losing the source trail.
- Selection
- Demand observed
- Identity
- NASDAQ:META
- Research
- Evidence first
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (+11.04% over the window).
Source rail: Yahoo Finance chart API (META). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for META. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
Atlas Pro artifact
META Market Snapshot PDF
The latest snapshot audit passed. Atlas checks entitlement and evidence again when the PDF is requested.
A retained research PDF is available to Atlas Pro accounts. Snapshot checks remain separate.
META public profile
Listed company. Meta Platforms Inc. is connected to current market context, cited company sources and its retained research file.
Meta Platforms Inc. trades as META on NASDAQ. Meta Platforms Inc. (META) has a latest verified close of 578.85, down 3.38%, dated 12 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files META under USA Stocks, Technology Stocks and Consumer Stocks for browsing.
What changed for Meta Platforms Inc. today
Meta Platforms, Inc. filed a first-quarter 2026 Form 10-Q that reads less like a technology company and more like a cash machine disguised as one. Revenue clocked $56.31 billion for the three months ended 31 March 2026, up from the same quarter last year but still only the third-largest quarter in the company’s history. Net income attributable to parent was $26.77 billion-so large it makes the rest of the S&P 500 look like a hobbyist spreadsheet. Operating income, at $22.87 billion, suggests the ad auctions are still running hotter than the server farms.
Meta’s balance sheet is the kind that makes central bankers weep into their spreadsheets: $395.25 billion of assets against $151.57 billion of liabilities, leaving $243.68 billion of shareholders’ equity. Cash and equivalents sat at $23.43 billion at quarter-end, while operating cash flow printed $32.23 billion-enough to buy Apple, Microsoft and Nvidia and still tip the bank. Capex chewed up $19 billion, mostly for AI infrastructure, and R&D swallowed another $17.70 billion, a sum that could fund the entire output of the Cannes film festival for a decade. Diluted EPS of $10.44 was earned across 2.56 billion shares-handy math if you’re calculating how many private islands that buys.
The filing’s footnotes confirm what the polished brochures omit: the company has no meaningful single-product dependency story to rely on. Advertising still drives the engine, and its reliability is the reason the cash registers keep ringing. No segment-level breakdown is disclosed, so we cannot parse how much of that $56.31 billion came from Reels, Reels Ads, AI chatbots, or whatever new product the comms team is calling “Meta Horizon Next” this week. The absence of granularity is not a crime, but it does make life harder for anyone trying to handicap the next inflection point.
If you want to see the company’s product roadmap in real time, you’ll have to watch the shareholder proposal theatre: the May 2026 annual meeting minutes show one proposal asking for a report on addressing antisemitism and hate in online platforms. The board “recommended voting against” the proposal, which is corporate code for “we already have a slide on this.” (source: 10-Q, period ending 2026-03-31, https://www.sec.gov/Archives/edgar/data/1326801/000095010326011028/xslF345X06/ownership.xml)
The SEC submissions index for CIK 1326801 offers a daily feed of Forms 3, 4 and 144, which is useful if you enjoy watching restricted stock units vaporise like dry ice under a spotlight. Recent filings show a cluster of lapses in July 2026, releasing Class A shares tied to 2018, 2019 and 2020 grant dates. The filing trail is precise, the optics are neat, and the dilution math is left as an exercise for the reader. (source: SEC EDGAR filing index for CIK 1326801, https://www.sec.gov/edgar/browse/?CIK=1326801)
For data nerds who like to trace the plumbing, the company’s XBRL company facts feed is the cleanest way to pull the raw numbers, but be warned: it rewards patience more than epiphany. The feed confirms every revenue line and expense head in the 10-Q, yet offers no forward-looking guidance-because why spoil the surprise? (source: SEC company facts JSON, https://data.sec.gov/api/xbrl/companyfacts/CIK0001326801.json)
Sources & evidence · 10 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
META technical readout
Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on META
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep META research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
META FAQ
What is Meta Platforms Inc. (META)?Meta Platforms Inc. (META) has a latest verified close of 578.85, down 3.38%, dated 12 Aug 2026. Use this page to check the price chart, company context, source-backed...
Meta Platforms Inc. (META) has a latest verified close of 578.85, down 3.38%, dated 12 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for META?Meta Platforms Inc. (META) has a latest verified close of 578.85, down 3.38%, dated 12 Aug 2026. It brings the latest available chart, company context, cited sources,...
Meta Platforms Inc. (META) has a latest verified close of 578.85, down 3.38%, dated 12 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files META under USA Stocks, Technology Stocks and Consumer Stocks for browsing.
How often is the META page updated?The META public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The META public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for META?The META file starts with NASDAQ symbol identity and TradingView NASDAQ:META. The page separates verified market context from company evidence and shows open evidence...
The META file starts with NASDAQ symbol identity and TradingView NASDAQ:META. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on META?Yes. The workstation can open META, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open META, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this META page investment advice?No. The META page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The META page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
META
Equity · evidence first